SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001731122-22-000196
Filing Date
2022-02-09
Accepted
2022-02-09 16:30:39
Documents
44
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q e3475_10q.htm   iXBRL 10-Q 505657
2 EXHIBIT 31.1 e3475_ex31-1.htm EX-31.1 7828
3 EXHIBIT 31.2 e3475_ex31-2.htm EX-31.2 8023
4 EXHIBIT 32.1 e3475_ex32-1.htm EX-32.1 5571
5 GRAPHIC image_001.jpg GRAPHIC 102574
6 GRAPHIC image_002.jpg GRAPHIC 94833
  Complete submission text file 0001731122-22-000196.txt   3071943

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE avxl-20211231.xsd EX-101.SCH 24462
8 XBRL CALCULATION FILE avxl-20211231_cal.xml EX-101.CAL 27532
9 XBRL DEFINITION FILE avxl-20211231_def.xml EX-101.DEF 87149
10 XBRL LABEL FILE avxl-20211231_lab.xml EX-101.LAB 201962
11 XBRL PRESENTATION FILE avxl-20211231_pre.xml EX-101.PRE 157311
38 EXTRACTED XBRL INSTANCE DOCUMENT e3475_10q_htm.xml XML 331653
Mailing Address 51 W 52ND STREET, 7TH FLOOR NEW YORK NY 10019-6163
Business Address 51 W 52ND STREET, 7TH FLOOR NEW YORK NY 10019-6163 800-689-3939
ANAVEX LIFE SCIENCES CORP. (Filer) CIK: 0001314052 (see all company filings)

IRS No.: 208365999 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 001-37606 | Film No.: 22607648
SIC: 2836 Biological Products, (No Diagnostic Substances)